BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29747998)

  • 21. Promoting Endochondral Bone Repair Using Human Osteoarthritic Articular Chondrocytes.
    Bahney CS; Jacobs L; Tamai R; Hu D; Luan TF; Wang M; Reddy S; Park M; Limburg S; Kim HT; Marcucio R; Kuo AC
    Tissue Eng Part A; 2016 Mar; 22(5-6):427-35. PubMed ID: 26830207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling.
    Hayata T; Ezura Y; Asashima M; Nishinakamura R; Noda M
    J Bone Miner Res; 2015 Feb; 30(2):318-29. PubMed ID: 25155999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII.
    Macsai CE; Derrick-Roberts AL; Ding X; Zarrinkalam KH; McIntyre C; Anderson PH; Anson DS; Byers S
    Mol Genet Metab; 2012 Jun; 106(2):202-13. PubMed ID: 22525091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification.
    Hattori T; Müller C; Gebhard S; Bauer E; Pausch F; Schlund B; Bösl MR; Hess A; Surmann-Schmitt C; von der Mark H; de Crombrugghe B; von der Mark K
    Development; 2010 Mar; 137(6):901-11. PubMed ID: 20179096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of established bone pathology in MPS VII mice following lentiviral-mediated gene therapy.
    Derrick-Roberts AL; Panir K; Pyragius CE; Zarrinkalam KH; Atkins GJ; Byers S
    Mol Genet Metab; 2016 Nov; 119(3):249-257. PubMed ID: 27692945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of substance P and the sympathetic nervous system impact on bone structure and chondrocyte differentiation in an adult model of endochondral ossification.
    Niedermair T; Kuhn V; Doranehgard F; Stange R; Wieskötter B; Beckmann J; Salmen P; Springorum HR; Straub RH; Zimmer A; Grifka J; Grässel S
    Matrix Biol; 2014 Sep; 38():22-35. PubMed ID: 25063231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
    Sands MS; Barker JE; Vogler C; Levy B; Gwynn B; Galvin N; Sly WS; Birkenmeier E
    Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
    Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
    Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of lithium administration on vertebral bone disease in mucopolysaccharidosis I dogs.
    Lau YK; Peck SH; Arginteanu T; Wu M; Lin M; Shore EM; Klein PS; Casal ML; Smith LJ
    Bone; 2022 Jan; 154():116237. PubMed ID: 34695616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of shortened bones in mucopolysaccharidosis VII.
    Metcalf JA; Zhang Y; Hilton MJ; Long F; Ponder KP
    Mol Genet Metab; 2009 Jul; 97(3):202-11. PubMed ID: 19375967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.
    Kingma SDK; Wagemans T; IJlst L; Bronckers ALJJ; van Kuppevelt TH; Everts V; Wijburg FA; van Vlies N
    Bone; 2016 Jul; 88():92-100. PubMed ID: 27105565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of growth plate angiogenesis and endochondral ossification with diminished expression of MMP-13 in hypertrophic chondrocytes in FGF-2-treated rats.
    Nagai H; Aoki M
    J Bone Miner Metab; 2002; 20(3):142-7. PubMed ID: 11984696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphological influence of ascorbic acid deficiency on endochondral ossification in osteogenic disorder Shionogi rat.
    Sakamoto Y; Takano Y
    Anat Rec; 2002 Oct; 268(2):93-104. PubMed ID: 12221715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
    Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS
    Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII.
    Barker JE; Deveau S; Lessard M; Hamblen N; Vogler C; Levy B
    Blood Cells Mol Dis; 2001; 27(5):861-73. PubMed ID: 11783949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel model of murine mucopolysaccharidosis type VII due to an intracisternal a particle element transposition into the beta-glucuronidase gene: clinical and pathologic findings.
    Vogler C; Levy B; Galvin N; Sands MS; Birkenmeier EH; Sly WS; Barker J
    Pediatr Res; 2001 Mar; 49(3):342-8. PubMed ID: 11228259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.
    Sly WS; Vogler C; Grubb JH; Zhou M; Jiang J; Zhou XY; Tomatsu S; Bi Y; Snella EM
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2205-10. PubMed ID: 11226217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.
    Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez MA; Dieter T; Sukegawa K; Orii T; Kondo N; Sly WS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14982-7. PubMed ID: 12403825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.
    Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS
    J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormalities in neural progenitor cells in a dog model of lysosomal storage disease.
    Walton RM; Wolfe JH
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):760-9. PubMed ID: 17882020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.